| Dr Yenney E Meza, MD | |
|
809 82nd Pkwy, Myrtle Beach, SC 29572-4607 | |
| (843) 449-9559 | |
| Not Available |
| Full Name | Dr Yenney E Meza |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 25 Years |
| Location | 809 82nd Pkwy, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225241854 | NPI | - | NPPES |
| 300025 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 30002 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Medical Center | Monroe, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Urgent Care Llc | 4082802509 | 7 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Wayne Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982828943 PECOS PAC ID: 6103926241 Enrollment ID: O20070703000148 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Augusta Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518169168 PECOS PAC ID: 6608977251 Enrollment ID: O20070726000065 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Coweta Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245556588 PECOS PAC ID: 5395876452 Enrollment ID: O20100706000634 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Southern Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205136470 PECOS PAC ID: 4082802509 Enrollment ID: O20101228001013 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Georgia Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952746638 PECOS PAC ID: 4082853262 Enrollment ID: O20130619000316 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Emergency Group Of Columbus Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316458227 PECOS PAC ID: 2668735515 Enrollment ID: O20180406001191 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Entity Name | Heritage Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003321969 PECOS PAC ID: 6305100850 Enrollment ID: O20180509000280 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yenney E Meza, MD 1017 S Myrtle Dr, Surfside Beach, SC 29575-3234 Ph: (215) 300-4669 | Dr Yenney E Meza, MD 809 82nd Pkwy, Myrtle Beach, SC 29572-4607 Ph: (843) 449-9559 |
News Archive
A report from St. Jude Children's Research Hospital links inherited mutations in the BRCA2 gene with an increased risk of developing non-Hodgkin lymphoma in children and adolescents.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc. ("PenRad"), a leader in the development of mammography information systems (MIS) are pleased to announce the signing of a sales and distribution agreement for PenRad to incorporate Medipattern's B-CAD computer aided detection for breast ultrasound imaging product line.
By specifically deleting the adhesion protein d-catenin, which is found exclusively in the brain, researchers at UCLA have found evidence that loss of d-catenin produces severe cognitive and synaptic dysfunction.
This week, I answered questions from three readers who are anxious about what the House-passed health reform bill might mean for them.
› Verified 9 days ago
Benjamin Tyler Mckinney, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1000 | |
Dr. Michael Coletta, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1000 | |
Kaitlyn Phelps, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-692-1752 | |
Dr. Edward W King, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2102 Cromley Cir Ste A, Myrtle Beach, SC 29577 Phone: 843-999-0064 | |
Daniel M Mcnabb, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Carolina Health Specialists 4615 Oleander Dr, Suite 201-a, Myrtle Beach, SC 29577 Phone: 843-449-9559 | |
Dalal A Akoury, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4710 Oleander Drive, Myrtle Beach, SC 29577 Phone: 843-213-1480 Fax: 843-712-1973 | |
Charles E. Tarbert, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-497-5929 Fax: 843-497-6601 |